Identification of Generic Drugs in the FDA Adverse Event Reporting System

被引：0
|
作者：
Iyer, Geetha S. [1 ,2 ]
Marimuthu, Sathiya Priya [1 ,3 ]
Segal, Jodi B. [1 ,2 ,4 ]
Singh, Sonal [1 ,4 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
696
引用
收藏
页码：406 / 407
页数：2
相关论文
共 50 条
  • [1] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Iyer, Geetha
    Marimuthu, Sathiya Priya
    Segal, Jodi B.
    Singh, Sonal
    [J]. DRUG SAFETY, 2017, 40 (09) : 799 - 808
  • [2] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Geetha Iyer
    Sathiya Priya Marimuthu
    Jodi B. Segal
    Sonal Singh
    [J]. Drug Safety, 2017, 40 : 799 - 808
  • [3] Patient Relevant Outcomes Associated with Generic Drugs in FDA's Adverse Event Reporting System
    Marimuthu, Sathiya Priya
    Iyer, Geetha S.
    Segal, Jodi B.
    Singh, Sonal
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 421 - 422
  • [4] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Pankdeep Chhabra
    Xing Chen
    Sheila R. Weiss
    [J]. Drug Safety, 2013, 36 : 1117 - 1123
  • [5] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Chhabra, Pankdeep
    Chen, Xing
    Weiss, Sheila R.
    [J]. DRUG SAFETY, 2013, 36 (11) : 1117 - 1123
  • [6] A Survey of the Most Common Drugs Causing Headaches in FDA Adverse Event Reporting System
    Musialowicz, B.
    Kamitaki, B.
    Zhang, P.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 82 - 82
  • [7] A survey of the most common drugs causing headaches in FDA adverse event reporting system
    Musialowicz, B.
    Kamitaki, B.
    Zhang, P.
    [J]. HEADACHE, 2021, 61 : 87 - 87
  • [8] A Survey of the Most Common Drugs Causing Headaches in FDA Adverse Event Reporting System
    Musialowicz, B.
    Kamitaki, B.
    Zhang, P.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 54 - 55
  • [9] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854
  • [10] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
12345